Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Return on Equity (2023 - 2025)

Neuraxis' Return on Equity history spans 3 years, with the latest figure at 2.15% for Q3 2025.

  • For Q3 2025, Return on Equity fell 430.0% year-over-year to 2.15%; the TTM value through Sep 2025 reached 2.15%, down 430.0%, while the annual FY2024 figure was 21.55%, 2346.0% down from the prior year.
  • Return on Equity for Q3 2025 was 2.15% at Neuraxis, up from 2.91% in the prior quarter.
  • Across five years, Return on Equity topped out at 5.41% in Q4 2023 and bottomed at 52.48% in Q4 2024.
  • The 3-year median for Return on Equity is 0.53% (2023), against an average of 4.45%.
  • The largest YoY upside for Return on Equity was 275bps in 2024 against a maximum downside of -5789bps in 2024.
  • A 3-year view of Return on Equity shows it stood at 5.41% in 2023, then crashed by -1070bps to 52.48% in 2024, then soared by 96bps to 2.15% in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Return on Equity are 2.15% (Q3 2025), 2.91% (Q2 2025), and 6.55% (Q1 2025).